Mojgan Mokhtari Selected Research

Immunotherapy

1/2022

Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mojgan Mokhtari Research Topics

Disease

11	Pre-Eclampsia (Preeclampsia) 01/2019 - 01/2011
8	Neoplasms (Cancer) 01/2024 - 08/2012
3	Spontaneous Abortion (Miscarriage) 08/2018 - 06/2017
3	Leiomyoma (Uterine Fibroids) 02/2017 - 08/2016
3	Gestational Diabetes (Gestational Diabetes Mellitus) 09/2011 - 06/2009
2	Breast Neoplasms (Breast Cancer) 05/2023 - 01/2018
2	Infections 01/2015 - 01/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024
1	Endometrial Neoplasms (Endometrial Cancer) 01/2024
1	Oropharyngeal Neoplasms 11/2022
1	COVID-19 07/2022
1	Mycoses (Diseases, Fungus) 07/2022
1	Cicatrix (Scar) 01/2022
1	Neoplasm Metastasis (Metastasis) 09/2020
1	Melanoma (Melanoma, Malignant) 09/2020
1	Body Weight (Weight, Body) 01/2020
1	Bile Reflux 01/2019
1	Obesity 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Carcinogenesis 02/2017
1	Celiac Disease (Celiac Sprue) 01/2015
1	Diabetes Mellitus 01/2015
1	Adenocarcinoma 08/2013
1	Collagenous Colitis 02/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2018 - 02/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2018 - 12/2015
2	CollagenIBA 01/2024 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019 - 01/2011
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	LeptinIBA 01/2014 - 09/2011
1	Estrogen ReceptorsIBA 05/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022
1	PlatinumIBA 01/2022
1	CurcuminIBA 09/2020
1	Therapeutic UsesIBA 09/2020
1	PhytochemicalsIBA 09/2020
1	PolyphenolsIBA 09/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	MicellesIBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	Antisense RNA (Anti-Sense RNA)IBA 08/2019
1	LipidsIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Chemotactic FactorsIBA 10/2018
1	InterferonsIBA 10/2018
1	Transcobalamins (Transcobalamin II)IBA 08/2018
1	HLA-G Antigens (HLA G)IBA 06/2017
1	Cyclin D1IBA 02/2017
1	Estrogen Receptor alphaIBA 01/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2016
1	Estrogens (Estrogen)FDA Link 08/2016
1	EnzymesIBA 08/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2015
1	factor V LeidenIBA 06/2015
1	Prothrombin (Factor II)IBA 06/2015
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2015
1	Glutens (Glutelin)IBA 01/2015
1	Interleukin-4 (Interleukin 4)IBA 01/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014
1	eosinylphosphatidylethanolamine (EOPE)IBA 01/2014
1	AdiponectinIBA 01/2014
1	ParaffinIBA 08/2013
1	Calcibiotic Root Canal SealerIBA 08/2012
1	ErbB Receptors (EGF Receptor)IBA 08/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Aryldialkylphosphatase (Paraoxonase)IBA 05/2011
1	arylesteraseIBA 05/2011
1	Angiotensin IIIBA 01/2011
1	Type 1 Angiotensin ReceptorIBA 01/2011
1	Adenosine DeaminaseIBA 04/2010
1	TrypsinIBA 06/2009

Therapy/Procedure

4	Therapeutics 07/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Length of Stay 07/2022
1	Immunotherapy 01/2022
1	Radiotherapy 01/2022
1	Cesarean Section (Caesarean Section) 01/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2019
1	Debridement 01/2015